Sarana Meditama Metropolitan (SAME) - Cash Flow Conversion Efficiency

Latest as of March 2026: 0.011x

Based on the latest financial reports, Sarana Meditama Metropolitan (SAME) has a cash flow conversion efficiency ratio of 0.011x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rp47.11 Billion ≈ $2.76 Million USD) by net assets (Rp4.19 Trillion ≈ $245.55 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See operational self-sufficiency of Sarana Meditama Metropolitan to measure how many days the company can operate on defensive assets alone.

Sarana Meditama Metropolitan - Cash Flow Conversion Efficiency Trend (2011–2025)

This chart illustrates how Sarana Meditama Metropolitan's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Sarana Meditama Metropolitan Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Sarana Meditama Metropolitan ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Hubtown Limited NSE:HUBTOWN	0.035x
Bintang Oto Global Tbk PT JK:BOGA	0.031x
Vodafone Group PLC LSE:VOD	0.163x
Colonial Coal International Corp V:CAD	-0.023x
UNID Company Ltd KO:014830	-0.030x
EuroHold Bulgaria AD WAR:EHG	0.020x
AVCON Information Tech SHE:300074	0.014x
Eledon Pharmaceuticals Inc NASDAQ:ELDN	-0.103x

Annual Cash Flow Conversion Efficiency for Sarana Meditama Metropolitan (2011–2025)

The table below shows the annual cash flow conversion efficiency of Sarana Meditama Metropolitan from 2011 to 2025. For the full company profile with market capitalisation and key ratios, see how much is Sarana Meditama Metropolitan worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	Rp4.17 Trillion ≈ $244.10 Million	Rp357.02 Billion ≈ $20.92 Million	0.086x	+34.64%
2024-12-31	Rp4.14 Trillion ≈ $242.49 Million	Rp263.42 Billion ≈ $15.44 Million	0.064x	+67.33%
2023-12-31	Rp3.98 Trillion ≈ $233.42 Million	Rp151.55 Billion ≈ $8.88 Million	0.038x	+1481.24%
2022-12-31	Rp3.98 Trillion ≈ $233.39 Million	Rp9.58 Billion ≈ $561.51K	0.002x	-95.80%
2021-12-31	Rp4.43 Trillion ≈ $259.67 Million	Rp253.74 Billion ≈ $14.87 Million	0.057x	+244.24%
2020-12-31	Rp545.82 Billion ≈ $31.98 Million	Rp-21.67 Billion ≈ $-1.27 Million	-0.040x	-120.60%
2019-12-31	Rp977.50 Billion ≈ $57.28 Million	Rp188.40 Billion ≈ $11.04 Million	0.193x	+716.24%
2018-12-31	Rp1.33 Trillion ≈ $77.70 Million	Rp31.31 Billion ≈ $1.83 Million	0.024x	-62.85%
2017-12-31	Rp1.04 Trillion ≈ $61.07 Million	Rp66.26 Billion ≈ $3.88 Million	0.064x	-56.32%
2016-12-31	Rp850.97 Billion ≈ $49.86 Million	Rp123.85 Billion ≈ $7.26 Million	0.146x	+10.60%
2015-12-31	Rp741.18 Billion ≈ $43.43 Million	Rp97.53 Billion ≈ $5.71 Million	0.132x	-77.37%
2014-12-31	Rp191.08 Billion ≈ $11.20 Million	Rp111.12 Billion ≈ $6.51 Million	0.582x	+3.41%
2013-12-31	Rp133.01 Billion ≈ $7.79 Million	Rp74.80 Billion ≈ $4.38 Million	0.562x	-80.36%
2012-12-31	Rp19.22 Billion ≈ $1.13 Million	Rp55.04 Billion ≈ $3.23 Million	2.863x	+137.81%
2011-12-31	Rp-4.05 Billion ≈ $-237.07K	Rp30.64 Billion ≈ $1.80 Million	-7.573x	--

About Sarana Meditama Metropolitan

JK:SAME Indonesia Medical Care Facilities

Market Cap

$299.72 Million

Rp5.12 Trillion IDR

Market Cap Rank

#14919 Global

#174 in Indonesia

Share Price

Rp298.00

Change (1 day)

-0.67%

52-Week Range

Rp246.00 - Rp428.00

All Time High

Rp755.00